ZA9810603B - Putamen Ovi. - Google Patents

Putamen Ovi.

Info

Publication number
ZA9810603B
ZA9810603B ZA9810603A ZA9810603A ZA9810603B ZA 9810603 B ZA9810603 B ZA 9810603B ZA 9810603 A ZA9810603 A ZA 9810603A ZA 9810603 A ZA9810603 A ZA 9810603A ZA 9810603 B ZA9810603 B ZA 9810603B
Authority
ZA
South Africa
Prior art keywords
putamen ovi
ovi
putamen
medicaments
locally
Prior art date
Application number
ZA9810603A
Inventor
Michel O Ruepp
Original Assignee
Michel O Ruepp Aar Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Michel O Ruepp Aar Pharma filed Critical Michel O Ruepp Aar Pharma
Publication of ZA9810603B publication Critical patent/ZA9810603B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Abstract

The invention relates to the use of treated putamen ovi in the production of medicaments which can be administered orally or locally for treatment and prevention.
ZA9810603A 1997-11-21 1998-11-19 Putamen Ovi. ZA9810603B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19751681A DE19751681A1 (en) 1997-11-21 1997-11-21 Use of Putamen ovi

Publications (1)

Publication Number Publication Date
ZA9810603B true ZA9810603B (en) 1999-08-02

Family

ID=7849459

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9810603A ZA9810603B (en) 1997-11-21 1998-11-19 Putamen Ovi.

Country Status (9)

Country Link
EP (1) EP1032407B1 (en)
AT (1) ATE249229T1 (en)
AU (1) AU1756299A (en)
CA (1) CA2311546A1 (en)
DE (2) DE19751681A1 (en)
DK (1) DK1032407T3 (en)
ES (1) ES2207020T3 (en)
WO (1) WO1999026641A1 (en)
ZA (1) ZA9810603B (en)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558771A (en) * 1968-02-12 1971-01-26 Leslie L Balassa Process for using eggshell compositions for promoting wound healing
GB2218906A (en) * 1988-05-27 1989-11-29 Anne Mcmanus Medicament for treatment of skin disorders
CS445488A1 (en) * 1988-06-24 1991-01-15 Karol Mvdr Michalek Biological preparation for osteo- and chondropathies,physiopathological disorders and diseases arisen on base of mineral deficiency in human organism treatment
CN1079149A (en) * 1993-04-09 1993-12-08 李洪洋 A kind of biological calcium element and preparation method thereof
DE4422613A1 (en) * 1994-06-28 1996-01-04 Aar Pharma Adler Apotheke Putamen ovi
NL1002400C2 (en) * 1996-02-20 1997-08-21 Friesland Brands Bv Oral calcitonin preparation and method of recovering calcitonin.
DE19627376A1 (en) * 1996-07-06 1998-01-08 Aar Pharma Adler Apotheke Use of Artichoke (Cynara) extracts
DE19639375A1 (en) * 1996-09-25 1998-04-02 Aar Pharma Mistletoe dry extracts
DE19700788A1 (en) * 1997-01-11 1998-07-16 Michael O Ruepp Use of a dry extract of St. John's wort

Also Published As

Publication number Publication date
CA2311546A1 (en) 1999-06-03
WO1999026641A1 (en) 1999-06-03
DK1032407T3 (en) 2004-01-12
DE19751681A1 (en) 1999-07-29
AU1756299A (en) 1999-06-15
EP1032407A1 (en) 2000-09-06
ATE249229T1 (en) 2003-09-15
ES2207020T3 (en) 2004-05-16
DE59809592D1 (en) 2003-10-16
EP1032407B1 (en) 2003-09-10

Similar Documents

Publication Publication Date Title
IL267381A (en) Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
GB2333453A (en) Colostrinin and uses thereof
NO954996D0 (en) Use of nona and decapeptides for the manufacture of a medicament for the treatment of AIDS
HU9603042D0 (en) Use of certain methanebisphosphonic acid derivatives to prevent or for treatment of prosthesis loosening and prosthesis migration
MY118526A (en) Method for improving the pharmacokinetics of tipranavir
WO1995031991A3 (en) Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases
HK1020867A1 (en) The topical use of kappa opioid agonists to treat ocular pain k
CA2418167A1 (en) Compositions and methods of preventing or reducing the risk or incidence of skeletal injuries in horses
AU5170499A (en) Use of ginkgo biloba extracts for preparing a medicine for treating amyotrophic lateral sclerosis
GB0020504D0 (en) Therapeutic method
PL338673A1 (en) Application of fanquinone in treating alzheimer disease
NZ326345A (en) Composition containing diosgenin
HK1047549A1 (en) Il6ril6 chimera for the treatment of neurodegeneraive diseases.
ZA9810603B (en) Putamen Ovi.
NO990450L (en) Treatment of mental disorders
PL329219A1 (en) Application of benzonaphtene derivatives in production of drugs for treating nervous system diseases
HK1044112A1 (en) Treatment of angiogenesis dependent conditions with dextrin sulphate.
WO2000067733A3 (en) Medicament for treating human infertility
UA27148C2 (en) Method for treating acute pyelonephritis
UA32580C2 (en) Drug for treatment of paralytic intestinal obstructioni
MD1664F1 (en) Method of ulcer recidivation prophylaxis
UA36251A (en) Method for complex treatment of simple schizophrenia
MX9605327A (en) Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration.
UA33498A (en) Method for treatment of resistant forms of schizophrenia